Pharma & Biopharma

This article explains how an inline probe was used to monitor a granulation at three different scales to confirm that, in each case, the granules produced were the same size, and more importantly produced tablets of identical quality as quantified by hardness.

Pat and Koen Sandra discuss the importance of 2D-LC for the advancement of biosimilars.

Fiona Greer explains how analytical tools can create the biosimilar “fingerprint.”

Innovation that takes technology design to the physical limits

NIBRT Principle Investigator Jonathan Bones discusses the challenges involved in biotherapeutic protein characterization.

Great technology takes complex challenges and provides simple, robust solutions.

Hear from industry expert Jason Creasey as he discusses the history of extractable and leachable testing

Hear how new developments in analytical technology are providing additional insights into unknown contaminants

Extractables and leachable compounds are a complex and ever growing list of pharmaceutical impurities

Hear from Kyle D’Silva as he discusses new developments in GC-MS technology for Extractables and Leachables testing